CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

8295	Companies
114809	Keywords
55260	Articles
62422	Press releases

Home
Companies
CROSSJECT

BRIEF

published on 08/22/2024 at 07:35, 2 months 30 days ago

Crossject to Participate in HC Wainwright’s 26th Annual Global Investment Conference

Investment Conference Crossject ZENEO® HC Wainwright
BRIEF

published on 08/22/2024 at 07:35, 2 months 30 days ago

Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright

Investissement Conference H.C. Wainwright Crossject ZENEO®
PRESS RELEASE

published on 08/22/2024 at 07:30, 2 months 30 days ago

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024
Crossject to present at H.C. Wainwright 26th Annual Global Investment Conference on September 9th-11th, 2024, showcasing their needle-free auto-injector ZENEO®

H.C. Wainwright Crossject Needle-free Auto-injector ZENEO® Global Investment Conference
PRESS RELEASE

published on 08/22/2024 at 07:30, 2 months 30 days ago

Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024
Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright du 9 au 11 septembre 2024, présentant son auto-injecteur primé ZENEO® pour les urgences médicales

Conference Crossject ZENEO® Investissement Global Auto-injecteur
BRIEF

published on 07/18/2024 at 07:35, 4 months 3 days ago

Crossject Achieves Key ZEPIZURE® Manufacturing Milestone

Crossject ZEPIZURE® Manufacturing Milestone FDA EUA ZENEO®
BRIEF

published on 07/18/2024 at 07:35, 4 months 3 days ago

Crossject franchit une étape clé dans la fabrication de ZEPIZURE®

ZEPIZURE® Projet Croisé ZENEO® Jalon De Fabrication EUA FDA
PRESS RELEASE

published on 07/18/2024 at 07:30, 4 months 3 days ago

Crossject achieves key ZEPIZURE® manufacturing milestone
Crossject achieves key ZEPIZURE manufacturing milestone with successful completion of new registration batch at Eurofins' qualified facility, supporting EUA timelines

Emergency Use Authorization Crossject ZEPIZURE Eurofins Manufacturing Milestone
BRIEF

published on 06/26/2024 at 07:35, 4 months 25 days ago

Crossject souligne le potentiel de ZEPIZURE® à la suite des études RAMPART et de bioéquivalence

Crossject ZEPIZURE® Midazolam Étude RAMPART Crises Épileptiques
BRIEF

published on 06/26/2024 at 07:35, 4 months 25 days ago

Crossject highlights the potential of ZEPIZURE® following RAMPART and bioequivalence studies

Crossject ZEPIZURE® Midazolam RAMPART Study Epileptic Seizures
PRESS RELEASE

published on 06/26/2024 at 07:30, 4 months 25 days ago

Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study
Crossject provides insights on ZEPIZURE® potential in light of RAMPART and its bioequivalence study. IM midazolam favored over IV lorazepam for emergency epilepsy management

Crossject ZEPIZURE RAMPART Study Bioequivalence Study Emergency Epilepsy Management

Accesswire

Published on 11/21/2024 at 09:00, 35 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 10 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 35 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 35 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:01, 34 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 35 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 35 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 20 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 25 minutes ago

KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 37 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 37 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 37 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 28 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 15 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE